None listed
Conditions
Interventions
Drug : They will be starting with NovoMix 30 FlexPen at a total daily dose of 0.3 U/kg body weight. It is recommended to give NovoMix 30 FlexPen twice daily at breakfast and at the evening main meal.
Sponsors
Inje University Sanggye Paik Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Type 2 diabetes according to WHO classification. 1) Treated with OAD(s) for at three months. 2) Age = 18 years. 3) Body mass index (BMI) = 25.0 kg/m2. 4) Glycosylated hemoglobin (HbA1c) = 7.5 % and = 10.0 % (both inclusive)
Exclusion criteria
Exclusion criteria: The patients who have history of drug or alcohol abuse, were treated with any other drug known to affect blood glucose (i.e., MAO-inhibitors, beta-adrenergic agents, anabolic steroids, and systemic glucocorticoids), have impaired renal function with serum creatinine = 1.7 mg/dL, have cardiac disease defined as: decompensated heart failure (NYHA classification III and IV), unstable angina pectoris, myocardial infarction within the last 12 months, or severe uncontrolled hypertension (systolic blood pressure when seated > 180 mmHg and/or diastolic blood pressure > 110 mmHg), or have proliferative retinopathy and/or advanced neuropathy as judged by the investigator. Pregnant or breast-feeding, or have the intention to become pregnant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c change | — |
Secondary
| Measure | Time frame |
|---|---|
| fasting glucose;7-point (before and after each meal and at bed time) SMBG | — |
Countries
Korea, Republic of
Contacts
Public ContactKee-Ho Song
Konkuk University Medical Center
Outcome results
None listed